Drug recall D-0577-2020
Product
25% Dextrose Injection, USP 2.5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1775-10
Reason for recall
Labeling: Incorrect or Missing Lot and/or expiration date.
Lots and codes
Lot #: 80-292-EV, 1AUG2019 on carton. Expiration date printed on syringe is 1AUG2021 which is incorrect.
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 77,100 syringes
- Distribution
- Nationwide within the United States including Puerto Rico.
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 27, 2019
- Terminated
- January 14, 2022
Related products
- Dextrose – drug information
- NDC 0409-1775 Dextrose · Dextrose Monohydrate 250 mg/mL · Hospira, Inc.